Evaluation of the chads2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope

Clinical Cardiology

Volumn 36, Issue 5, 2013, Pages 262-268

  Ruwald, Martin Huth ^a   Ruwald, Anne Christine ^a   Jons, Christian ^a   Lamberts, Morten ^a   Hansen, Morten Lock ^a   Vinther, Michael ^a   Køber, Lars ^b   Torp Pedersen, Christian ^a   Hansen, Jim ^a   Gislason, Gunnar Hilmar ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL EVALUATION; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; EMERGENCY WARD; FAINTNESS; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK ASSESSMENT; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; EVALUATION STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SYNCOPE; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DENMARK; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SYNCOPE; TIME FACTORS;

EID: 84877763117     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22102     Document Type: Article

References (36)

1. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285: 2864-2870.
2. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011; 342: d124.
3. Crandall MA, Horne BD, Day JD, et al. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol. 2009; 32: 981-986.
4. Kim YD, Cha MJ, Kim J, et al. Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS score. Thromb Haemost. 2011; 105: 712-720.
5. Nakagawa K, Hirai T, Takashima S, et al. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am J Cardiol. 2011; 107: 912-916.
6. Khumri TM, Idupulapati M, Rader VJ, et al. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. Am J Cardiol. 2007; 99: 1733-1736.
7. Ruiz-Nodar JM, Marin F, Manzano-Fernandez S, et al. An evaluation of the CHADS stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest. 2011; 139: 1402-1409.
8. Chao TF, Cheng CC, Lin WS, et al. Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2011; 8: 1155-1159.
9. Chao TF, Ambrose K, Tsao HM, et al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm. 2012; 9: 1185-1191.
10. Pouleur AC, Barkoudah E, Uno H, et al. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010; 122: 597-602.
11. Huikuri HV, Castellanos A, Myerburg RJ,. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001; 345: 1473-1482.
12. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J. 2005; 26: 1385-1393.
13. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002; 347: 878-885.
14. Ruwald MH, Hansen ML, Lamberts M, et al. The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study. Europace. 2012; 14: 1506-1514.
15. Gaist D, Sorensen HT, Hallas J,. The Danish prescription registries. Dan Med Bull. 1997; 44: 445-448.
16. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46: 263-268.
17. Ruwald MH, Hansen ML, Lamberts M, et al. Accuracy of the ICD-10 discharge diagnosis for syncope [published online ahead of print November 4, 2012 ]. Europace. doi: 10.1093/europace/eus359.
18. Krarup LH, Boysen G, Janjua H, et al. Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology. 2007; 28: 150-154.
19. Madsen M, Davidsen M, Rasmussen S, et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003; 56: 124-130.
20. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med. 2011; 105: 1063-1068.
21. Kumler T, Gislason GH, Kirk V, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008; 10: 658-660.
22. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012; 367: 625-635.
23. Sorensen R, Hansen ML, Abildstrom SZ, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009; 374: 1967-1974.
24. Nielsen SF, Nordestgaard BG, Bojesen SE,. Statin use and reduced cancer-related mortality. N Engl J Med. 2012; 367: 1792-1802.
25. Lidegaard O, Lokkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012; 366: 2257-2266.
26. Andersson C, Norgaard ML, Hansen PR, et al. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail. 2010; 12: 1333-1338.
27. Schramm TK, Gislason GH, Kober L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008; 117: 1945-1954.
28. Ruwald MH, Hansen ML, Lamberts M, et al. Prognosis among healthy individuals discharged with a primary diagnosis of syncope. J Am Coll Cardiol. 2013; 61: 325-332.
29. Quinn J, McDermott D, Stiell I, et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006; 47: 448-454.
30. Colivicchi F, Ammirati F, Melina D, et al. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003; 24: 811-819.
31. Reed MJ, Newby DE, Coull AJ, et al. The ROSE (Risk Stratification of Syncope in the Emergency Department) study. J Am Coll Cardiol. 2010; 55: 713-721.
32. Reed MJ, Henderson SS, Newby DE, et al. One-year prognosis after syncope and the failure of the ROSE decision instrument to predict one-year adverse events. Ann Emerg Med. 2011; 58: 250-256.
33. Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008; 94: 1620-1626.
34. Kapoor WN, Hanusa BH,. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med. 1996; 100: 646-655.
35. Middlekauff HR, Stevenson WG, Stevenson LW, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993; 21: 110-116.
36. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009; 30: 2631-2671.